[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361913-105":59,"doc-detail-361913-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","genetically-proxied-therapeutic-effect-of-antihypertensive-drug-use-breast-cancer-and-ovarian-cancers-risk","Genetically proxied therapeutic effect of antihypertensive drug use, breast cancer, and ovarian cancer’s risk: a drug-target Mendelian randomization study","","Background observational studies assess whether antihypertensive drugs relate to breast cancer (BC) and ovarian cancer (OC) risk, but results remain inconsistent. This two-sample Mendelian randomization (MR) study investigates causal effects using genetic proxies for antihypertensive drug use. Analyses employed inverse variance weighted (IVW) estimation with heterogeneity and horizontal pleiotropy tests, plus sensitivity analyses, to evaluate robustness and causal strength. Genetically predicted calcium channel blockers increased OC risk under Bonferroni-corrected thresholds, with no evidence for other antihypertensive drugs.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genetically-proxied-therapeutic-effect-of-antihypertensive-drug-use-breast-cancer-and-ovarian-cancers-risk/361913/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genetically-proxied-therapeutic-effect-of-antihypertensive-drug-use-breast-cancer-and-ovarian-cancers-risk/361913.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study?","Question",{"text":112,"@type":113},"To evaluate the causal relationship between genetic proxies for antihypertensive drug use and the risk of breast and ovarian cancers using two-sample Mendelian randomization.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which antihypertensive drug class showed a causal association with ovarian cancer risk?",{"text":117,"@type":113},"Genetically predicted calcium channel blockers (CCBs) increased the risk of ovarian cancer, supported by Bonferroni-corrected significance thresholds in the MR analyses described.",{"name":119,"@type":110,"acceptedAnswer":120},"How were the results tested for robustness and potential bias?",{"text":121,"@type":113},"The study used inverse variance weighted (IVW) as the primary method, with heterogeneity and horizontal pleiotropy tests and additional sensitivity analyses to assess robustness and causal strength.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361913,1790219319,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Dang et al. BMC Cancer (2025) 25:1125 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14350-2](https://doi.org/10.1186/s12885-025-14350-2)  \nRESEARCH Open Access  \nGenetically proxied therapeutic effect of antihypertensive drug use, breast cancer, and ovarian cancer’s risk: a drug-target Mendelian randomization study  \nChunxiao Dang 1†, Ruohan Wang2†, Yunzhen Shi3, Pengfei Liu 1, Xiaofeng Wang2, Jinxing Liu 1, Xiao Yu4, Dongxu Jin2* and Qing Ma4*  \nAbstract  \nBackground Observational studies have explored the association between antihypertensive drugs and the risk of breast cancer (BC) and ovarian cancer (OC) . However, some controversy persists.  \nObjective Our study aims to investigate the causal relationship between genetic proxies for antihypertensive drugs and breast and ovarian cancers using two-sample Mendelian randomization (MR) analysis.  \nMethods Analyses were primarily conducted using the inverse variance weighted (IVW) method, with heterogeneity and horizontal pleiotropy tests, as well as sensitivity analysis, to assess the robustness of the results and the strength of the causal relationship.  \nResults Using the Bonferroni-corrected P-value as the threshold for testing causality (P \u003C 0. 0025), the MR analysis of systolic blood pressure as a biomarker in subset (A) (OR = 1 . 059, 95% CI: 1 .024–1. 096, P = 9.581 × 10− 4) and subset (B) (OR = 1 . 000, 95% CI: 1 .000-1. 001, P = 6.726 × 10− 4) both found that genetically predicted calcium channel blockers (CCBs) increased the risk of ovarian cancer. The same result was found only in subset (B) in the MR analysis of diastolic blood pressure as a biomarker (OR = 1 . 001, 95% CI: 1 .000-1. 001, P = 3.465 × 10− 4), while subset (A) showed a suggestive association between CCBs and the risk of ovarian cancer development (OR = 1 . 088, 95% CI: 1.027–1. 153, P = 0 . 004) . Neither heterogeneity nor horizontal pleiotropy was detected, and no evidence of an association between other antihypertensive drugs and breast or ovarian cancer was found.  \nConclusions Our study provides genetic evidence that CCBs increase the risk of OC, offering insight into the potential risks of pharmacological treatment with CCBs.  \nKeywords Antihypertensive drugs, Breast cancer, Ovarian cancer, Mendelian randomization, Drug-Target MR  \n†Chunxiao Dang and Ruohan Wang contributed equally to this work.  \n*Correspondence: Dongxu Jin [1142163524@qq.com](1142163524@qq.com)[ ](1142163524@qq.com)Qing Ma[maqing918@yeah.net](maqing918@yeah.net)  \n1First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China  \n2Dongying People’s Hospital (Dongying Hospital of Shandong Provincial Hospital Group), South Road No. 317, Dongying, Shandong 257091, China 3Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China  \n4Department of Gynecology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jingshi Road No. 16369, Jinan 250014, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this l","cbCaifBdzcTnJg5j","https://ap.wps.com/l/cbCaifBdzcTnJg5j","pdf",1514531,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main goal of this study?\",\"answer\":\"To evaluate the causal relationship between genetic proxies for antihypertensive drug use and the risk of breast and ovarian cancers using two-sample Mendelian randomization.\"},{\"question\":\"Which antihypertensive drug class showed a causal association with ovarian cancer risk?\",\"answer\":\"Genetically predicted calcium channel blockers (CCBs) increased the risk of ovarian cancer, supported by Bonferroni-corrected significance thresholds in the MR analyses described.\"},{\"question\":\"How were the results tested for robustness and potential bias?\",\"answer\":\"The study used inverse variance weighted (IVW) as the primary method, with heterogeneity and horizontal pleiotropy tests and additional sensitivity analyses to assess robustness and causal strength.\"}]","Genetically proxied therapeutic effect of antihypertensive drug use, breast cancer, and ovarian cancer’s risk: a drug-target Mendelian randomization study | PDF",1790145967,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ae91688fbc7bb8fc7d2a3b9b173f0a4.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfc04344ec82dfcbe60b4beffe170927.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e810ef15ad1fb8dc980c680ba10b2ec5.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b456f5d032f9def6117ac8c8f66d397.webp",980,1306]